So, while HIF-1α antagonizes c-MYC-induced proliferation, HIF-2α increases it by potentiating the oncogenic effect of c-MYC in an in vitro model with VHL-deficient renal cell carcinoma [108]. Here, EPAS1 is linked to hereditary clear cell renal cell carcinoma.